表紙
市場調査レポート

世界の陽子線治療市場の将来展望

Global Proton Therapy Outlook 2018

発行 RNCOS E-Services Pvt. Ltd. 商品コード 305567
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
世界の陽子線治療市場の将来展望 Global Proton Therapy Outlook 2018
出版日: 2014年06月01日 ページ情報: 英文 90 Pages
概要

世界各国で近年、新たながん治療法の一種である陽子線治療への関心が急速に高まってきました。健康な組織に悪影響を与えることなく、従来よりも多量の放射線を標的に照射できることから、陽子線治療はがん治療の世界における次世代の主力技術として急速に普及しています。事実、この5年間で世界各地に陽子線治療センターが多数開設されました。

当レポートでは、世界の主要国(イタリア・フランス・日本・ドイツ・中国・英国)における陽子線治療市場の将来動向について分析し、現在利用されている放射線治療の概要や、陽子線治療の特徴、関連部品市場の将来動向(今後5年間分)、各国市場のマクロ環境と今後の市場機会、主要企業のプロフィルと競争力・製品構成といった情報をお届けいたします。

第1章 アナリストの見解

第2章 分析手法

第3章 現在の放射線治療

  • 三次元原体照射療法(CRT)
  • 画像誘導放射線治療(IGRT)
  • 強度変調放射線治療(IMRT)
  • 定位放射線治療
  • 中性子治療
  • 陽子線治療
  • なぜ陽子線治療なのか?

第4章 標準的な陽子線治療施設の構成機器

  • 陽子加速器
  • ビーム輸送システム
  • ビームデリバリーシステム
  • ノズル
    • 単一拡散
    • 二重拡散
    • 均一走査ノズル
    • 光速型走査ノズル
  • 治療計画システム
  • 画像ビューア
  • 患者整位システム
  • 人材

第5章 主要国の陽子線治療市場の将来展望

  • 日本
    • 人口構造
    • マクロ経済指標
    • 疾患のプロファイル
    • 陽子線治療の現状
    • 市場機会の評価
  • ドイツ
  • 中国
  • 英国

第6章 競争環境と戦略分析

  • IBA
  • 日立製作所
  • Varian
  • 三菱電機
  • 住友重機械工業

図表一覧

目次

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without affecting the healthy tissues, it is being promulgated as the next big thing in the world of cancer treatment. In fact, the past five years have witnessed a surge in the number of proton therapy centers that have been established globally.

According to our report, "Global Proton Therapy Outlook 2018", 16 such centers have been established across Italy, France, Japan, Germany, China and UK in the past 5 years. Even though many centers have been established and the future is set to witness the inception of more, given the capacity of the facilities, there exists a huge demand and supply gap.

Through our report, we have deduced this gap and the true demand for proton centers by 2018. The derivation has been performed with the help of a complex matrix that takes into account the contribution of various parameters such as cancer incidences, types of cancers for which proton therapy is recommended, affordability of individuals across various geographies, and total patient treatment capacity of existing centers and those that are expected to come up by 2018.

In the Geographic Assessment section, we have provided a detailed analysis of four geographies namely, Japan, Germany, China and UK. These geographies have been selected after intensive research on status of factors such as the prevailing and upcoming proton centers, cancer incidences and affordability in these regions. For every region, a demographic outline has been carved to help the reader understand the population trends and the contribution of various age groups in total population. Next, we have highlighted the 'macro-economic indicators' of the country which includes trends in GDP, household incomes, disposable incomes etc. These indicators are necessary as they help in evaluating the demand for a costly treatment like Proton Therapy.

Following this, we have provided the reader with an outlook of the Current Status of Proton Therapy, which includes the likes of existing and upcoming centers along with their details such as vendors available, number of rooms, year of operation etc. Finally, in the opportunity assessment chapter, we have deduced the number of potential patients whose demand for proton therapy will remain unmet in 2018 and subsequently we have estimated the number of facilities that would be required to cater to these patients. For certain geographies, we have also provided a list of potential hospitals that might want to diversify their services by offering proton therapy.

Lastly, in the competitive landscape chapter, we have introduced the reader to the major players of the industry and touched upon every player's strength and weakness in terms of their proton therapy product portfolio. The report serves as a must read for anyone willing to invest in this promising area and trying to evaluate opportunities. It is also beneficial for equipment vendors who would like an insight into their position in the industry and how they can improve upon the same.

Table of Contents

1. Analyst View

2. Research Methodology

3. Current Radiation Therapies

  • 3.1 Third Dimensional Conformal Therapy (CRT)
  • 3.2 Image Guided Radiotherapy (IGRT)
  • 3.3 Intensity Modulated Radiotherapy (IMRT)
  • 3.4 Stereotactic Radiotherapy
  • 3.5 Neutron Therapy
  • 3.6 Proton Therapy
    • 3.6.1 Why Proton Therapy?

4. Components of a Standard Proton Therapy Center

  • 4.1 Proton Accelerator
  • 4.2 Beam Transport System
  • 4.3 Beam Delivery System
  • 4.4 Nozzle
    • 4.4.1 Single Scattering
    • 4.4.2 Double Scattering
    • 4.4.3 Uniform Scanning Nozzle
    • 4.4.4 Pencil Scanning Nozzle
  • 4.5 Treatment Planning System
  • 4.6 Image Viewers
  • 4.7 Patient Positioning System
  • 4.8 Human Resource

5. Proton Therapy: Geographic Assessment to 2018

  • 5.1 Japan
    • 5.1.1 Demographics
    • 5.1.2 Macro-Economic Indicators
    • 5.1.3 Disease Profiling
    • 5.1.4 Current Status of Proton Therapy
    • 5.1.5 Opportunity Assessment
  • 5.2 Germany
    • 5.2.1 Demographics
    • 5.2.2 Macro-Economic Indicators
    • 5.2.3 Disease Profiling
    • 5.2.4 Current Status of Proton Therapy
    • 5.2.5 Opportunity Assessment
  • 5.3 China
    • 5.3.1 Demographics
    • 5.3.2 Macro-Economic Indicators
    • 5.3.3 Disease Profiling
    • 5.3.4 Current Status of Proton Therapy
    • 5.3.5 Opportunity Assessment
  • 5.4 UK
    • 5.4.1 Demographics
    • 5.4.2 Macro-Economic Indicators
    • 5.4.3 Disease Profiling
    • 5.4.4 Current Status of Proton Therapy
    • 5.4.5 Opportunity Assessment

6. Competitive Landscape and Strategic Analysis

  • 6.1 IBA
  • 6.2 Hitachi
  • 6.3 Varian
  • 6.4 Mitsubishi
  • 6.5 Sumitomo Heavy Industries

List of Figures:

  • Figure 3-1: Advantages of Proton Therapy over Conventional Radiation Therapy
  • Figure 4-1: Investment Break-up for a Proton Therapy Center
  • Figure 4-2: Maximum Number of Patients that can be treated based on Number of Rooms
  • Figure 4-3: Components of a Proton Therapy Center
  • Figure 5-1: Japan - Population (Million), 2013-2018
  • Figure 5-2: Japan - Age-wise Breakup of Population (%), 2013 & 2018
  • Figure 5-3: Japan - Number of Households (Million), 2013-2018
  • Figure 5-4: Japan - Nominal GDP (Trillion US$), 2013-2018
  • Figure 5-5: Japan - Personal Disposable Income per Head (US$), 2013-2018
  • Figure 5-6: Japan - Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
  • Figure 5-7: Japan - Cancer Incidence (000), 2009 & 2020
  • Figure 5-8: Japan - Number of Proton Therapy Centers (2013 & 2018)
  • Figure 5-9: Japan - Proton Therapy Centers by Number of Rooms (2013 & 2018)
  • Figure 5-10: Japan - Demand of Single Room Proton Therapy Centers by 2018
  • Figure 5-11: Germany - Population (Million), 2013-2018
  • Figure 5-12: Germany - Age-wise Breakup of Population (%), 2013 & 2018
  • Figure 5-13: Germany - Number of Households (Million), 2013-2018
  • Figure 5-14: Germany - Nominal GDP (Trillion US$), 2013-2018
  • Figure 5-15: Germany - Personal Disposable Income per Head (US$), 2013-2018
  • Figure 5-16: Germany - Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
  • Figure 5-17: Germany - Cancer Incidence (000), 2009 & 2020
  • Figure 5-18: Germany - Number of Proton Therapy Centers (2013 & 2018)
  • Figure 5-19: Germany - Proton Therapy Centers by Number of Rooms (2013 & 2018)
  • Figure 5-20: Germany - Demand of Proton Therapy Centers by 2018
  • Figure 5-21: China - Population (Million), 2013-2018
  • Figure 5-22: China - Age-wise Breakup of Population (%), 2013 & 2018
  • Figure 5-23: China - Number of Households (Million), 2013-2018
  • Figure 5-24: China - Nominal GDP (Trillion US$), 2013-2018
  • Figure 5-25: China - Personal Disposable Income per Head (US$), 2013-2018
  • Figure 5-26: China - Number of Households Earning > US$ 75,000 p.a. (Million), 2013-2018
  • Figure 5-27: China - Cancer Incidence (Million), 2009 & 2020
  • Figure 5-28: China - Number of Proton Therapy Centers (2013 & 2018)
  • Figure 5-29: China - Proton Therapy Centers by Number of Rooms (2013 & 2018)
  • Figure 5-30: China - Demand of Proton Therapy Centers by 2018
  • Figure 5-31: UK - Population (Million), 2013-2018
  • Figure 5-32: UK - Age-wise Breakup of Population (%), 2013 & 2018
  • Figure 5-33: UK - Number of Households (Million), 2013-2018
  • Figure 5-34: UK - Nominal GDP (Trillion US$), 2013-2018
  • Figure 5-36: UK - Number of Household Earning > US$ 75,000 p.a. (Million), 2013-2018
  • Figure 5-37: UK - Cancer Incidence (Million), 2011 & 2020
  • Figure 5-40: UK - Demand of Proton Therapy Centers by 2018
  • Figure 6-1: IBA - Breakdown of Revenue by Activity (%), 2013

List of Tables:

  • Table 4-1: Capital Investment and Land Requirement for Proton Therapy Center
  • Table 4-2: Human Resource Requirements and their role in Proton Therapy Center
  • Table 5-1: Japan - Top 15 Cancer Types by Incidence (2009)
  • Table 5-2: Japan - Top 15 Cancer Types by Mortality (2009)
  • Table 5-3: Japan - Existing Proton Therapy Facilities (2013)
  • Table 5-4: Japan - Upcoming Proton Therapy Facilities (2014-2018)
  • Table 5-5: Japan - Potential Patients for Proton Therapy (2013 & 2018)
  • Table 5-6: Germany - Top 15 Cancer Types by Incidence (2009)
  • Table 5-7: Germany - Top 15 Cancer Types by Mortality (2009)
  • Table 5-8: Germany - Existing Proton Therapy Facilities (2013)
  • Table 5-9: Germany - Upcoming Proton Therapy Facilities (2014-2018)
  • Table 5-10: Germany - Potential Patients for Proton Therapy (2013 & 2018)
  • Table 5-11: Germany - List of Potential Hospitals
  • Table 5-12: China - Top 15 Cancer Types by Incidence (2009)
  • Table 5-13: China - Top 15 Cancer Types by Mortality (2009)
  • Table 5-14: China - Existing Proton Therapy Facilities (2013)
  • Table 5-15: China - Upcoming Proton Therapy Facilities (2014-2018)
  • Table 5-16: China - Potential Patients for Proton Therapy (2013 & 2018)
  • Table 5-17: China - List of Potential Hospitals
  • Table 5-18: UK - Top 10 Cancer Types by Incidence (2011)
  • Table 5-19: UK - Top 10 Cancer Types by Mortality (2011)
  • Table 5-20: UK - Upcoming Proton Therapy Facilities (2014-2018)
  • Table 5-21: UK - Potential Patients for Proton Therapy (2013 & 2018)
  • Table 6-1: IBA - Proton Therapy Products and Services
  • Table 6-2: IBA - Key Financials (Million EUR), 2011-2013
  • Table 6-3: IBA - Proton Therapy Installations
  • Table 6-4: IBA - Strengths and Weaknesses
  • Table 6-5: Hitachi - Key Financials (Billion US$), 2011-2013
  • Table 6-6: Hitachi - Proton Therapy Installations
  • Table 6-7: Hitachi - Strengths and Weaknesses
  • Table 6-8: Varian - Proton Therapy Products and Services
  • Table 6-9: Varian - Key Financials (Billion US$), 2011-2013
  • Table 6-10: Varian - Proton Therapy Installations
  • Table 6-11: Varian - Strengths and Weaknesses
  • Table 6-12: Mitsubishi - Key Financials (Billion Yen), 2011-2013
  • Table 6-13: Mitsubishi - Proton Therapy Installations
  • Table 6-14: Mitsubishi - Strengths and Weaknesses
  • Table 6-15: Sumitomo - Key Financials (Billion Yen), 2011-2013
  • Table 6-16: Sumitomo - Proton Therapy Installations
  • Table 6-17: Sumitomo - Strengths and Weaknesses
Back to Top